Phathom Pharmaceuticals, Inc. · NASDAQ:PHAT

James N. Topper reported a 19.90% stake in Phathom Pharmaceuticals, Inc. (Schedule 13D/A)

Event May 9, 2025 · Filed May 13, 2025

James N. Topper reported a 19.90% stake in Phathom Pharmaceuticals, Inc., 14,429,990 shares, with active intent on May 9, 2025. Filed May 13, 2025 (Schedule 13D/A).

Stake
19.90%
Shares
14,429,990
Intent
Active
What changed
Stake changed
Filed together
23 holders

The filing in full

HolderStakeShares
Frazier Life Sciences Public Fund, L.P.8.00%5,738,457
FHMLSP, L.P.8.00%5,738,457
FHMLSP, L.L.C.8.00%5,738,457
Frazier Life Sciences Public Overage Fund, L.P.2.20%1,531,870
FHMLSP Overage, L.P.2.20%1,531,870
FHMLSP Overage, L.L.C.2.20%1,531,870
Frazier Life Sciences X, L.P.0.10%48,203
FHMLS X, L.P.0.10%48,203
FHMLS X, L.L.C.0.10%48,203
Frazier Life Sciences XI, L.P.1.40%961,550
FHMLS XI, L.P.1.40%961,550
FHMLS XI, L.L.C.1.40%961,550
Frazier Life Sciences IX, L.P.8.30%5,827,415
FHMLS IX, L.P.8.30%5,827,415
FHMLS IX, L.L.C.8.30%5,827,416
Frazier Life Sciences XII, L.P.0.30%223,986
FHMLS XII, L.P.0.30%223,986
FHMLS XII, L.L.C.0.30%223,986
James N. Topper19.90%14,429,990
Patrick J. Heron19.90%14,346,419
Albert Cha10.10%7,270,327
James Brush10.10%7,270,327
Daniel Estes1.70%1,185,536

Source

View original at SEC

Related